Whether this is due to a clinically important increase in hypoglycaemia with insulin or because hyperglycaemia is an epiphenomenon [26] rather than a mediator of a poor outcome, these discrepancies indicate a need to look beyond the hyperglycaemia itself and explore the related pathophysiology. The gene discussed is INS; the disease is Hyperglycemia.